Australian Trachoma Surveillance Report update: 2014–2022
DOI:
https://doi.org/10.33321/cdi.2025.49.006Keywords:
trachoma, SAFE control strategy, surveillance, eliminationAbstract
Australia is the only high-income country where trachoma has been endemic, defined as an overall trachoma prevalence in Aboriginal and Torres Strait Islander children aged 5–9 years of 5% or more. The Australian Government funds the National Trachoma Surveillance and Reporting Unit to collate and analyse trachoma prevalence data and control strategies annually. This report presents data submitted from 2014 to 2022. In 2022, there were 87 remote communities considered at-risk of endemic trachoma, a decline of 51% since 2014 when 177 communities were considered at-risk. World Health Organization grading criteria are used to diagnose trachoma in at-risk populations. Overall prevalence, which includes estimates from all communities ever considered at-risk, fell below 5% endemicity thresholds for the first time in 2022 in Western Australia (2.9%), the Northern Territory (2.1%), New South Wales (0.5%), and in Queensland and South Australia (0.0% each). New cases of trachomatous trichiasis—a severe consequence of trachoma that causes blindness—were detected in eight out of 10,806 persons, aged 15 years and over, screened in 2022. Jurisdictional trichiasis prevalence was 0.2% in Western Australia, 0.1% in South Australia and 0.0% in the Northern Territory. Australia must maintain overall trachoma and trichiasis prevalence below endemicity levels for a further two years before applying for World Health Organization validation of elimination of trachoma as a public health problem.
Downloads
References
WHO Alliance for the Global Elimination of Trachoma. Progress report on elimination of trachoma, 2022. Wkly Epidemiol Rec. 2023;98(28):297–314. Available from: https://iris.who.int/handle/10665/371094.
Elwell C, Mirrashidi K, Engel J. Chlamydia cell biology and pathogenesis. Nat Rev Microbiol. 2016;14(6):385–400. doi: https://doi.org/10.1038/nrmicro.2016.30.
Taylor HR, Johnson SL, Schachter J, Caldwell HD, Prendergast RA. Pathogenesis of trachoma: the stimulus for inflammation. J Immunol. 1987;138(9):3023–7. doi: https://doi.org/10.4049/jimmunol.138.9.3023.
Solomon AW, Kello AB, Bangert M, West SK, Taylor HR, Tekeraoi R et al. The simplified trachoma grading system, amended. Bull World Health Organ. 2020;98(10):698–705. doi: https://doi.org/10.2471/BLT.19.248708.
Merbs S, Resnikoff S, Kello AB, Mariotti S, Greene G, West SK. Trichiasis surgery for trachoma, Second Edition. Geneva: World Health Organization (WHO); 9 July 2015. Available from: https://www.who.int/publications/i/item/9789241549011.
West SK, Muñoz B, Mkocha H, Hsieh YH, Lynch MC. Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol. 2001;8(2–3):137–44. doi: https://doi.org/10.1076/opep.8.2.137.4158.
Habtamu E, Wondie T, Aweke S, Tadesse Z, Zerihun M, Zewdie Z et al. Trachoma and relative poverty: a case-control study. PLoS Negl Trop Dis. 2015;9(11):e0004228. doi: https://doi.org/10.1371/journal.pntd.0004228.
Stocks ME, Ogden S, Haddad D, Addiss DG, McGuire C, Freeman MC. Effect of water, sanitation, and hygiene on the prevention of trachoma: a systematic review and meta-analysis. PLoS Med. 2014;11(2):e1001605. doi: https://doi.org/10.1371/journal.pmed.1001605.
Last A, Versteeg B, Shafi Abdurahman O, Robinson A, Dumessa G, Abraham Aga M et al. Detecting extra-ocular Chlamydia trachomatis in a trachoma-endemic community in Ethiopia: identifying potential routes of transmission. PLoS Negl Trop Dis. 2020;14(3):e0008120. doi: https://doi.org/10.1371/journal.pntd.0008120.
Solomon AW, Holland MJ, Burton MJ, West SK, Alexander ND, Aguirre A et al. Strategies for control of trachoma: observational study with quantitative PCR. Lancet. 2003;362(9379):198–204. doi: https://doi.org/10.1016/S0140-6736(03)13909-8.
Cowling CS, Liu BC, Snelling TL, Ward JS, Kaldor JM, Wilson DP. Australian trachoma surveillance annual report, 2013. Commun Dis Intell Q Rep. 2016;40(2):E255–66.
Taylor HR, Fox SS, Xie J, Dunn RA, Arnold ALMR, Keeffe JE. The prevalence of trachoma in Australia: the National Indigenous Eye Health Survey. Med J Aust. 2010;192(5):248–53. doi: https://doi.org/10.5694/j.1326-5377.2010.tb03501.x.
WHO Alliance for the Global Elimination of Trachoma. Progress report, 2019. Wkly Epidemiol Rec. 2020;95(30):349–60. Available from: https://iris.who.int/handle/10665/333443.
WHO. Validation of elimination of trachoma as a public health problem. Geneva: WHO; 4 June 2016. Available from: https://www.who.int/publications/i/item/who-htm-ntd-2016.8.
WHO. Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030. Geneva: WHO; 28 January 2021. Available from: https://www.who.int/publications/i/item/9789240010352.
Kuper H, Solomon AW, Buchan J, Zondervan M, Foster A, Mabey D. A critical review of the SAFE strategy for the prevention of blinding trachoma. Lancet Infect Dis. 2003;3(6):372–81. doi: https://doi.org/10.1016/s1473-3099(03)00659-5.
Liu B, Cowling C, Hayen A, Watt G, Mak DB, Lambert S et al. Relationship between community drug administration strategy and changes in trachoma prevalence, 2007 to 2013. PLoS Negl Trop Dis. 2016;10(7):e0004810. doi: https://doi.org/10.1371/journal.pntd.0004810.
Warren JM, Birrell AL. Trachoma in remote Indigenous Australia: a review and public health perspective. Aust N Z J Public Health. 2016;40(Suppl 1):S48–52. doi: https://doi.org/10.1111/1753-6405.12396.
Ewald DP, Hall GV, Franks CC. An evaluation of a SAFE-style trachoma control program in Central Australia. Med J Aust. 2003;178(2):65–8. doi: https://doi.org/10.5694/j.1326-5377.2003.tb05065.x.
Wright HR, Keeffe JE, Taylor HR. Barriers to the implementation of the SAFE strategy to combat hyperendemic trachoma in Australia. Ophthalmic Epidemiol. 2010;17(6):349–59. doi: https://doi.org/10.3109/09286586.2010.528135.
Communicable Diseases Network Australia (CDNA). CDNA national guidelines for the public health management of trachoma. Canberra: Australian Government Department of Health and Aged Care, CDNA; 31 January 2014. Available from: https://www.health.gov.au/sites/default/files/documents/2020/02/trachoma-cdna-national-guidelines-for-public-health-units.pdf.
WHO. Trachoma control: a guide for programme managers. Geneva: WHO; 20 July 2006. Available from: https://www.who.int/publications/i/item/9241546905.
The National Trachoma Surveillance and Reporting Unit. Australian Trachoma Surveillance Report 2021. Sydney: University of New South Wales, The Kirby Institute, WHO Collaborating Centre in Neglected Tropical Diseases; 2022. Available from: https://www.kirby.unsw.edu.au/sites/default/files/documents/TRACHOMA_2021.pdf.
WHO. Report of the 4th global scientific meeting on trachoma: Geneva, 27–29 November 2018. Geneva: WHO; 4 June 2019. Available from: https://www.who.int/publications/i/item/who-htm-ntd-pct-2019.03.
Dirani M, Keel S, Foreman J, van Wijngaarden P, Taylor HR. Prevalence of trachomatous trichiasis in Australia: the National Eye Health Survey. Clin Exp Ophthalmol. 2018;46(1):13–7. doi: https://doi.org/10.1111/ceo.13003.
Australian Bureau of Statistics (ABS). Housing statistics for Aboriginal and Torres Strait Islander peoples. [Internet.] Canberra: ABS; 16 September 2021. [Accessed on 22 August 2023.] Available from: https://www.abs.gov.au/statistics/people/aboriginal-and-torres-strait-islander-peoples/housing-statistics-aboriginal-and-torres-strait-islander-peoples/latest-release.
Standen JC, Morgan GG, Sowerbutts T, Blazek K, Gugusheff J, Puntsag O et al. Prioritising housing maintenance to improve health in Indigenous communities in NSW over 20 years. Int J Environ Res Public Health. 2020;17(16):5946. doi: https://doi.org/10.3390/ijerph17165946.
Wyber R, Kelly A, Lee AM, Mungatopi V, Kerrigan V, Babui S et al. Formative evaluation of a community-based approach to reduce the incidence of Strep A infections and acute rheumatic fever. Aust N Z J Public Health. 2021;45(5):449–54. doi: https://doi.org/10.1111/1753-6405.13127.
Johnston L, Doyle J, Morgan B, Atkinson-Briggs S, Firebrace B, Marika M et al. A review of programs that targeted environmental determinants of Aboriginal and Torres Strait Islander health. Int J Environ Res Public Health. 2013;10(8):3518–42. doi: https://doi.org/10.3390/ijerph10083518.
Lea T, Grealy L, Moskos M, Brambilla A, King S, Habibis D et al. Final Report No. 368: Sustainable Indigenous housing in regional and remote Australia. Melbourne: Australian Housing and Urban Research Institute Limited; 4 November 2021. doi: https://doi.org/10.18408/ahuri7323701.
WHO. Informal consultation on end-game challenges for trachoma elimination, Task Force for Global Health, Decatur, United States of America, 7–9 December 2021. Geneva: WHO; 18 October 2022. Available from: https://www.who.int/publications/i/item/9789240048089.
Quesada-Cubo V, Damián-González DC, Prado-Velasco FG, Fernández-Santos NA, Sánchez-Tejeda G, Correa-Morales F et al. The elimination of trachoma as a public health problem in Mexico: from national health priority to national success story. PLoS Negl Trop Dis. 2022;16(8):e0010660. doi: https://doi.org/10.1371/journal.pntd.0010660.
Hammou J, Mohammadi F, Raisi AA, Harbi SA. Sustaining trachoma elimination: lessons from North Africa and the Middle East. Community Eye Health. 2019;32(105):23.
Senyonjo LG, Debrah O, Martin DL, Asante-Poku A, Migchelsen SJ, Gwyn S et al. Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem. PLoS Negl Trop Dis. 2018;12(12):e0007027. doi: https://doi.org/10.1371/journal.pntd.0007027.
Lynch KD, Brian G, Ahwang T, Morotti W, Wharton G, Newie T et al. Assessing the prevalence of trachoma: lessons from community screening with laboratory testing in Australia’s Torres Strait Islands. Ophthalmic Epidemiol. 2022;30(6):663–670. doi: https://doi.org/10.1080/09286586.2022.2136389.
Aboe A, Joof BM, Kanyi SK, Hydara A, Downs P, Bush S et al. The Gambia has eliminated trachoma as a public health problem: challenges and successes. PLoS Negl Trop Dis. 2022;16(3):e0010282. doi: https://doi.org/10.1371/journal.pntd.0010282.
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
